Company news
Eco Animal Health Group Plc (LSE:EAH) news
Eco Animal Health Group Plc news releases on 6ix. Latest, Mar 21, 2024: Replacement: Trading Update
Press releases — page 2
Replacement: Trading Update
March 21, 2024
General Meeting Result
March 19, 2024
Publication of Notice of General Meeting
February 27, 2024
Board Appointment
February 12, 2024
Trademark Approval for ECOVAXXIN® family in the EU
February 6, 2024
Disposal of Freehold Properties
January 8, 2024
Deferred Option Awards to Executive Directors
December 22, 2023
Investor Presentation
November 27, 2023
Capital Markets Day Events
November 9, 2023
New USA and Canada label claim for Aivlosin®
October 24, 2023
ESG Rating
September 28, 2023
Notice of AGM
August 10, 2023
Posting of the Annual Report and Accounts
July 21, 2023
Final Results for the Year Ended 31 March 2023
July 10, 2023
Notice of Results & Investor Presentation
July 5, 2023
Issue of Equity and Total Voting Rights
June 6, 2023
Animal Health Innovation Summit
March 8, 2023
Change of Registered Address
February 24, 2023
Deferred Share Option Awards
December 13, 2022
Results for the six months ended 30 September 2022
November 23, 2022
Investor Presentation covering Interim Results
November 22, 2022
Change of Auditor
November 14, 2022
Publication of Annual Report and Notice of AGM
September 2, 2022
Final Results for the Year Ended 31 March 2022
August 31, 2022
Revised Notice of Results
August 22, 2022
Directorate Change
August 9, 2022
Second Price Monitoring Extn
August 8, 2022
New Banking Facility
July 11, 2022
Partnership with Moredun Research Institute
July 6, 2022
Partnership with Imperial College
June 15, 2022
Director/PDMR Dealings
May 12, 2022
Director/PDMR Dealing
March 23, 2022
Pre-close Trading Update
March 15, 2022
New Marketing Authorisations for Aivlosin in China
February 23, 2022
Chief Executive Officer Appointment
January 18, 2022
Trading update, Appointment of Joint Broker & CMD
January 12, 2022
Director Dealings
November 30, 2021
Results for the six months ended 30 September 2021
November 25, 2021
Total Voting Rights & Share Capital
October 1, 2021
Deferred Share Awards to Executive Directors
September 27, 2021
AGM Statement
September 16, 2021
Directors Dealings
July 28, 2021
Final Results for Year Ended 31 March 2021
July 26, 2021
Total Voting Rights
May 28, 2021
Result of AGM & GM
March 4, 2021
Clarification of new long term incentive plan
February 25, 2021
Annual & Interim Reports Publication & AGM Notice
February 4, 2021
AIVLOSIN® USA & CANADIAN MARKETING AUTHORISATIONS
January 13, 2021
Swine Vaccine Brazilian Marketing Authorisation
January 7, 2021
Results for year ended 31 March 2020 delayed
December 21, 2020